About Topogen
Topogen is a Healthcare company based in Denver (United States) founded in 1991. Products and services for topoisomerase research are provided to scientists. Topogen offers products and services including Topo Enzymes, Assay Kits, DNA Gyrases, Antibodies, and Drug Screening Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is TopoGEN, Inc. Its competitors include GenScript, OriGene and Meridian Bioscience; 2 of its 3 listed competitors have raised funding.
Company details
Provider of products and services for researchers. The company offers drug screening kits to identify topoisomerase active drugs, kits for assaying both prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase); DNA substrates and DNA cleavage targets, topoisomerase inhibitors, topoisomerase antibodies, and kit replenishment reagents. The company is developing diagnostic tests for bladder cancer (IHC based test); scleroderma and multiple sclerosis. It also provides drug screening services.
- Headquarters Denver, United States
- SectorsHealthcare
- Email••••••••
- Website topogen.com
- Social LinkedIn X Facebook YouTube
- Legal Name Topogen, Inc.
- Latest Funding Round$750.82K (USD), Grant
Aug 2020
- Investors
Products & Services of Topogen
Topogen offers a comprehensive portfolio of products and services, including Topo Enzymes, Assay Kits, DNA Gyrases, Antibodies, and Drug Screening Kits.
High-purity enzymes for topoisomerase research
Optimized kits for DNA repair and drug screening
Enzymes for bacterial DNA gyrase studies
Validated antibodies for topoisomerase detection
Kits for identifying topo-targeting drugs
Apps and channels of Topogen
its YouTube channel TopoGEN, Inc. has 44 subscribers.
Funding Insights of Topogen
- Total Rounds 6
- Last Round Grant — $750,819
- First Round $153,630
(Jul 2008)
- Investors Count 1
All 6 funding rounds of Topogen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Topogen
Topogen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Topogen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Topogen
3 dated milestones of Topogen across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Topogen is founded.
- Funding First funding round of $154K.
- Funding Latest funding round, Grant, of $751K.
Competitors of Topogen
Topogen has 3 listed competitors in our database, 2 of them funded. They include GenScript, OriGene and Meridian Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits |
Detailed competitors of Topogen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Topogen
The website of Topogen (topogen.com) receives about 3.9K visits a month.
- Monthly visits3.9K
▼ 13.1% vs previous month
Websites whose visitors overlap most with Topogen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| usp.org | 100% | 538.7K | #106,934 | View details | |
| trinitybiotech.com | 100% | 9.3K | #2,475,266 | View details | |
| amriglobal.com | 66% | 680.7K | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Topogen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Topogen
Topogen was founded in 1991 and raised its 1st funding round 17 years after it was founded.
Topogen is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Provider of products and services for researchers. The company offers drug screening kits to identify topoisomerase active drugs, kits for assaying both prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase); DNA substrates and DNA cleavage targets, topoisomerase inhibitors, topoisomerase antibodies, and kit replenishment reagents. The company is developing diagnostic tests for bladder cancer (IHC based test); scleroderma and multiple sclerosis. It also provides drug screening services.
Topogen's top competitors include Meridian Bioscience, GenScript and OriGene.
Topogen offers Topo Enzymes, Assay Kits, DNA Gyrases, Antibodies, and Drug Screening Kits.
Topogen has 1 investor. Key investors include HHS.
Topogen operates through Topogen, Inc..